BIONICS 12 Months Outcomes

 

 Randomized Non-Inferiority Pivotal Study

 

 

Target Lesion Failure (TLF) at 12 Months 

 

 

Stent Thrombosis at 12 Months 

 

• The EluNIR stent demonstrated excellent clinical results and was non-inferior to Resolute at 12 months in a broad, less selected ‘more comers’ population
• EluNIR demonstrated low stent thrombosis rates with no events beyond 30 days  

 

 

 

Randomized Non-Inferiority Pivotal Study 

 

 

In Stent Late-Loss at 6 Months 

 

 

 Clinical Outcomes at 12 Months

 

• The EluNIR stent demonstrated a remarkably low in-stent late lumen loss and was non-inferior to Resolute at 6 months
• Low events rates at 12 months 

  

 

Trial Design

   

 

 


NIREUS: BioNIR Ridaforolimus Eluting Coronary Stent System European Angiography Study (CIP Number: BioNIR-002)

BIONICS: BioNIR Ridaforolimus Eluting Coronary Stent System In Coronary Stenosis Trial (CIP Number: BioNIR-001)

Accordion Title: 
NIRxcell Clinical Data
NIRTRAKS
Icon: 
class="block__title block-title">Download file

© 2016 Medinol Ltd · MKW1015-2